Showing results (31-40 of 214) with videos related to
Sort By:
Pageof 22
Current Pharmaceutical Design|March 28, 2013
Systems biology approaches to pancreatic cancer detection, prevention and treatmentOsama M Alian, Philip A Philip, Fazlul H Sarkar, et al.Molecular Cancer Therapeutics|December 24, 2005
Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapyShadan Ali, Basil F El-Rayes, Fazlul H Sarkar, et al.International Journal of Oncology|December 4, 2009
Angiogenesis: an update and potential drug approaches (review)Maen Abdelrahim, Santhi Konduri, Riyaz Basha, et al.Seminars in Cancer Biology|January 26, 2016
F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunitiesAmmar Sukari, Irfana Muqbil, Ramzi M Mohammad, et al.Journal of Clinical Medicine|June 21, 2016
The Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaMaria Diab, Irfana Muqbil, Ramzi M Mohammad, et al.Seminars in Cancer Biology|February 16, 2019
Ras and exosome signalingRachel E Sexton, Gabriel Mpilla, Steve Kim, et al.Breast Cancer Research and Treatment|November 28, 2002
Breast cancer in women with human immunodeficiency virus infection: implications for diagnosis and therapyBasil F El-Rayes, Kambeez Berenji, Paula Schuman, et al.Cancer|March 17, 2009
Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell linesShirish M Gadgeel, Shadan Ali, Philip A Philip, et al.Investigational New Drugs|May 10, 2006
A phase I study of flavopiridol and docetaxelBasil F El-Rayes, Shirish Gadgeel, Ralph Parchment, et al.Expert Opinion on Emerging Drugs|September 4, 2010
Emerging Bcl-2 inhibitors for the treatment of cancerAsfar S Azmi, Zhiwei Wang, Philip A Philip, et al.Pageof 22